Some of the top-grossing drugs include Merck's Keytruda, an immunotherapy for multiple cancers with almost $30 billion in ...

While 2025 was the year of disruption for Trump’s pharma policies, we expect 2026 to be the year of truth: will the US ...

Dublin, Jan. 05, 2026 (GLOBE NEWSWIRE) -- The "Pharma Contract Sales Market Report 2025-2035" has been added to ResearchAndMarkets.com's offering. The global Pharma Contract Sales Market is projected ...

2025 might shape out to be a boon year for pharma, a recent report from Norstella’s Evaluate suggests. The 2025 Preview Report examines the “biggest movers and shakers” in the biotech and pharma ...

The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2026, according to Statista. The oncology segment alone is expected to generate $232 billion in sales this year.

With sluggish pharmaceutical sales in the third quarter coming in below analysts’ expectations, Bayer is acutely aware of the challenges facing its key unit. Nevertheless, at least as far as ...

Earnings Call Insights: Roche Holding AG (OTCQX:RHHBY) Q4 2024 CEO Thomas Schinecker emphasized that 2024 was an "excellent ...

LONDON--(BUSINESS WIRE)--As coronavirus continues to wreak havoc across industries, Quantzig’s sales analytics experts analyze the recent challenges in the pharmaceutical industry and explain why a ...

CEO Eric Green highlighted that the company achieved 3.3% organic revenue growth in Q4 2024, marking a return to quarterly growth. Notable drivers included strong performance in Biologics and the ...

POMDOCTOR LIMITED ('Pomdoctor' or the 'Company') (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced significant progress in its strategic ...

ZURICH (Reuters) - Novartis expects sales at its pharmaceutical business to grow at a mid single-digit rate in the third quarter and at a high single-digit rate in the fourth on a local currency basis ...